Co-morbidities as predictors of airflow limitation among smokers in England

Kayyali, Reem, Hassan, Yusur, Hesso, Iman and Siva, Roshan (2018) Co-morbidities as predictors of airflow limitation among smokers in England. Pharmacy, 6(2), p. 45. ISSN (online) 2226-4787

Full text available as:
[img]
Preview
Text
Kayyali-R-41236-VoR.pdf - Published Version
Available under License Creative Commons Attribution.

Download (513kB) | Preview

Abstract

The prevalence of co-morbidities among patients with Chronic Obstructive Pulmonary Disease (COPD) is well documented in the literature. Therefore, this pilot study aimed to identify whether co-morbidities screening would enhance COPD case-finding. Smoking patients were approached at Croydon University Hospital and two local community pharmacies (CPs). Their co-morbidities, respiratory symptoms, smoking pack-years and exercise capacity were collected. Airflow limitation was determined using handheld spirometry (COPD-6) device. The prevalence of airflow limitation was 42% (n = 21/50). The main identified predictors of airflow limitation were: co-morbidities (OR = 9, CI: 1.04–77.81, p = 0.025), respiratory symptoms (OR = 33.54, CI: 1.06–11.77, p = 0.039) and smoking history of ≥20 pack-years (OR = 3.94, CI: 1.13–13.64, p = 0.029). CPs were the main location for case-finding. This study demonstrated the need to screen for co-morbidities for COPD case-finding within CPs.

Item Type: Article
Research Area: Allied health professions and studies
Faculty, School or Research Centre: Faculty of Science, Engineering and Computing > School of Life Sciences, Pharmacy and Chemistry
Depositing User: Katrina Clifford
Date Deposited: 29 Jun 2018 10:56
Last Modified: 29 Jun 2018 10:56
DOI: https://doi.org/10.3390/pharmacy6020045
URI: http://eprints.kingston.ac.uk/id/eprint/41236

Actions (Repository Editors)

Item Control Page Item Control Page